Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate the safety and effectiveness of JUVÉDERM VOLUX® to correct moderate to severe chin retrusion in Chinese adults.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04559984
Study type Interventional
Source Allergan
Status Completed
Phase Phase 3
Start date October 15, 2020
Completion date August 26, 2022

See also
  Status Clinical Trial Phase
Completed NCT03597256 - Restylane Defyne for Correction of Chin Retrusion N/A
Active, not recruiting NCT06336772 - Restylane Shaype Versus Juvederm Volux for Chin Augmentation N/A
Active, not recruiting NCT05777759 - Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile N/A
Completed NCT02833077 - A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation N/A
Completed NCT04687046 - A Study of JUVÉDERM VOLUX® Injectable Gel for Chin Enhancement in Chinese Adults Using Real-World Evidence
Completed NCT02559908 - A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw N/A
Completed NCT03624816 - A Study to Evaluate the Safety and Efficacy of Restylane Defyne for Chin Augmentation and Correction of Chin Retrusion N/A
Recruiting NCT05986630 - Safety and Effectiveness Evaluation of TEOSYAL® TPVM Versus COMPARATOR for the Remodeling of the Lower Face N/A